Kailera Therapeutics, Inc.(KLRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KLRA Kailera Therapeutics, Inc.

休市中 06-18 16:00:00 EDT

19.90

+0.77

+4.03%

盘后19.90

+0.000.00%

19:12 EDT

最高20.49	最低19.21	成交量435.59万
今开19.38	昨收19.13	日振幅6.69%
总市值25.78亿	流通市值8.94亿	总股本1.30亿
成交额8,656万	换手率9.70%	流通股本4,492万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KLRA","market":"US","secType":"STK","nameCN":"Kailera Therapeutics, Inc.","latestPrice":19.9,"timestamp":1781812800000,"preClose":19.13,"halted":0,"volume":4355889,"hourTrading":{"tag":"盘后","latestPrice":19.9,"preClose":19.9,"latestTime":"19:12 EDT","volume":1074217,"amount":21376856.5479,"timestamp":1781824372724,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.040250914793518014,"floatShares":44921899,"shares":129537300,"eps":-1.204378,"marketStatus":"休市中","change":0.77,"latestTime":"06-18 16:00:00 EDT","open":19.38,"high":20.49,"low":19.21,"amount":86561628.804258,"amplitude":0.066911,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.204378,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1782115200000},"marketStatusCode":7,"adr":0,"listingDate":1776398400000,"exchange":"NASDAQ","adjPreClose":19.13,"preHourTrading":{"tag":"盘前","latestPrice":19.52,"preClose":19.13,"latestTime":"08:46 EDT","volume":16,"amount":306.47,"timestamp":1781786800127,"change":0.39,"changeRate":0.020387,"amplitude":0.020387},"postHourTrading":{"tag":"盘后","latestPrice":19.9,"preClose":19.9,"latestTime":"19:12 EDT","volume":1074217,"amount":21376856.5479,"timestamp":1781824372724,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":8.179265298061729},"requestUrl":"/m/hq/s/KLRA","defaultTab":"news","newsList":[{"id":"1141920352","title":"Kailera Therapeutics 公布 HRS-7535 三期与 HRS-4729 一期试验积极顶线数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1141920352","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141920352?lang=zh_cn&edition=full","pubTime":"2026-05-27 04:08","pubTimestamp":1779826103,"startTime":"0","endTime":"0","summary":"Kailera Therapeutics 宣布，其候选药物 HRS-7535 的三期临床试验以及 HRS-4729 的一期临床试验均取得了积极的顶线数据结果。这一进展标志着公司在相关治疗领域的研发取得了重要突破，为后续的临床开发与监管申请奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195378546","title":"Kailera Therapeutics获Leerink Partners首次覆盖，给予“跑赢大盘”评级，目标价36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195378546","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195378546?lang=zh_cn&edition=full","pubTime":"2026-05-12 18:11","pubTimestamp":1778580703,"startTime":"0","endTime":"0","summary":"投资银行Leerink Partners宣布，对生物制药公司Kailera Therapeutics启动研究覆盖。该机构给予该公司股票“跑赢大盘”的初始评级，并设定了每股36美元的目标价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628766952","title":"减肥药企业Kailera纳斯达克上市：市值31亿美元 恒瑞医药成大赢家","url":"https://stock-news.laohu8.com/highlight/detail?id=2628766952","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628766952?lang=zh_cn&edition=full","pubTime":"2026-04-19 15:45","pubTimestamp":1776584754,"startTime":"0","endTime":"0","summary":"减肥药企业Kailera Therapeutics(股票代码：“KLRA”）日前在美国纳斯达克上市，发行价为16美元，发行3906万股，募资总额为6.24亿美元。","market":"sh","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260419/6391221034231146037652788.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260419/6391221034231146037652788.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n33340/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["LU0405327494.USD","GPIQ","QDTE","NVIW.SI","LU2495084118.USD","LU1146622755.USD","LU0359201885.HKD","LU1064131003.USD","BK0239","LU2289578879.USD","BK1147","IYW","LU2097828631.EUR","TQQY","LU1969619763.USD","QLD","LU1997245094.SGD","LU2328871848.SGD","QQQJ","LU1997244956.HKD","QID","LU2097828557.USD","LU1580142542.USD","QQQE","BK1191","ONEQ","LU1064130708.USD","SQQQ","QQQA","LU1781817850.SGD","LU2580892789.USD","QQQ","LU1328615791.USD","BK0196","LU1820825898.SGD","NQmain","LU2097828474.EUR","BK0060","LU0359202008.SGD","MNQmain","01276","LU0405327148.USD","LU1255011170.USD","LU2580892862.HKD","LU0359201612.USD","LU1023057109.AUD","600276","JEPQ","PSQ","LU2543165471.USD","BK0188","QYLG","QQQY","LU1655091616.SGD","QQQM","LU2148510915.USD","LU2488822045.USD","TQQQ","LU1997245177.USD","BK4007","LU2097828714.EUR","LU2097828805.USD","BK0028","KLRA","FTEC","BK0012","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136289592","title":"异动解读 | 凯莱拉治疗公司盘中大涨62.5%，受益于纳斯达克成功上市及减肥药市场广阔前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1136289592","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136289592?lang=zh_cn&edition=full","pubTime":"2026-04-18 01:27","pubTimestamp":1776446849,"startTime":"0","endTime":"0","summary":"凯莱拉治疗公司今日盘中股价大幅上涨62.50%，引起了市场的广泛关注。此次股价大涨与公司成功登陆纳斯达克密切相关。消息显示，凯莱拉治疗公司首次公开募股以每股16美元的价格发行，而市场预期其开盘价将达到32美元，远高于发行价，这反映了投资者对公司的高度认可和强烈兴趣。凯莱拉治疗公司的主要候选产品ribupatide作为一种每周注射一次的GLP-1药物，目前正处于后期试验阶段，这进一步增强了市场对其未来商业化前景的信心。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["KLRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628578522","title":"美股异动 | 减肥药新贵Kailera Therapeutics(KLRA.US)登陆美股市场 开盘暴涨超50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628578522","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628578522?lang=zh_cn&edition=full","pubTime":"2026-04-18 00:00","pubTimestamp":1776441606,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，减肥药新贵Kailera Therapeutics(KLRA.US)登陆美股市场，开盘暴涨超50%，报24.1美元，IPO价格为16美元。该公司创下2021年以来美国生物科技领域规模最大的IPO纪录。Kailera成立于2024年，是一家处于临床后期的生物科技公司，正在开发四种基于GLP-1的减肥药物，其中包括一款每周注射一次的药物和一款每日口服一次的药片，目前均已进入后期临床试验阶段。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430273.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KLRA","BK4539","BK4139","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628221198","title":"募资6.25亿美元创五年之最 减肥药新贵Kailera Therapeutics(KLRA.US)今晚登陆纳斯达克","url":"https://stock-news.laohu8.com/highlight/detail?id=2628221198","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628221198?lang=zh_cn&edition=full","pubTime":"2026-04-17 11:33","pubTimestamp":1776396818,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，专注于肥胖症治疗的临床阶段生物科技公司Kailera Therapeutics Inc.通过扩大首次公开发行规模，成功募资6.25亿美元，创下2021年以来美国生物科技领域规模最大的IPO纪录。根据周四发布的一份声明，Kailera以每股16美元的价格出售了约3900万股股票。包括贝恩资本旗下Bain Capital Private Equity、Bain Capital Life Sciences和卡塔尔投资局在内的现有股东已表示，有意按IPO价格合计购买最多2.25亿美元的公司股票。此次IPO之前，Kailera已于去年10月通过B轮融资募资6亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MNQmain","NVIW.SI","QQQA","IYW","QDTE","TQQY","QQQY","BK4139","QQQE","ONEQ","JEPQ","PSQ","QQQ","BK4007","QLD","QQQM","GPIQ","QYLG","BK4539","QQQJ","BK1147","KLRA","TQQQ","FTEC","SQQQ","QID"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627741817","title":"减肥药公司Kailera Therapeutics(KLRA.US)IPO定价14-16美元/股 拟周五登陆纳斯达克","url":"https://stock-news.laohu8.com/highlight/detail?id=2627741817","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627741817?lang=zh_cn&edition=full","pubTime":"2026-04-14 15:19","pubTimestamp":1776151188,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，专注于开发治疗肥胖症注射及口服GLP-1类药物的III期阶段生物技术公司Kailera Therapeutics于周一公布其首次公开募股条款。根据计划，Kailera 预计将于本周四晚间完成最终定价，并于次日在纳斯达克交易所挂牌交易。其核心候选药物ribupatide目前正在全球开展III期临床试验，这是一种每周一次注射的GLP-1/葡萄糖依赖性促胰岛素多肽受体双重激动剂肽。Kailera Therapeutics成立于2024年，计划在纳斯达克上市，股票代码为KLRA。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["JEPQ","KLRA","ONEQ","QQQA","QID","MNQmain","BK4007","QQQ","PSQ","NVIW.SI","QLD","IYW","FTEC","QQQM","TQQY","SQQQ","BK1147","TQQQ","BK4539","QYLG","QQQY","QQQJ","BK4139","GPIQ","QQQE","QDTE"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.kailera.com","stockEarnings":[{"period":"1week","weight":0.0184},{"period":"1month","weight":0.0143},{"period":"3month","weight":0.2437},{"period":"ytd","weight":0.2437}],"compareEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.1514},{"period":"6month","weight":0.0972},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.0951}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kailera Therapeutics, Inc.于2024年5月8日根据特拉华州法律注册成立。该公司是一家处于临床阶段的生物技术公司，致力于通过推进多元化的研发管线，引领肥胖症治疗的新时代。目前，该公司正在快速推进四款处于临床阶段的候选产品，这些产品利用多种基于胰高血糖素样肽-1 (GLP-1) 的作用机制和给药途径。","exchange":"NASDAQ","name":"Kailera Therapeutics, Inc.","nameEN":"Kailera Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kailera Therapeutics, Inc.(KLRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kailera Therapeutics, Inc.(KLRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kailera Therapeutics, Inc.,KLRA,Kailera Therapeutics, Inc.股票,Kailera Therapeutics, Inc.股票老虎,Kailera Therapeutics, Inc.股票老虎国际,Kailera Therapeutics, Inc.行情,Kailera Therapeutics, Inc.股票行情,Kailera Therapeutics, Inc.股价,Kailera Therapeutics, Inc.股市,Kailera Therapeutics, Inc.股票价格,Kailera Therapeutics, Inc.股票交易,Kailera Therapeutics, Inc.股票购买,Kailera Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kailera Therapeutics, Inc.(KLRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kailera Therapeutics, Inc.(KLRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}